MoneyWorks4Me

Indoco Remedies informs about allotment of ESOP

03 Feb 2026 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed that the Nomination and Remuneration Committee of the Company, in its meeting held today, 03rd February, 2026 has approved the allotment of 55,700 equity shares of face value of Rs 2 each to the Indoco Employees Welfare Trust (ESOP Trust) under Indoco Remedies Limited Employee Stock Option Plan - 2022 (Plan). The shares allotted to the ESOP Trust shall be allocated/ transferred to the Eligible Employees upon Exercise of Options and RSUs. Consequent to this allotment, the paid-up capital of the Company stands increased from to Rs. 18,44,95,810 (consisting of 9,22,47,905 equity shares of face value of Rs. 2 each) to Rs. 18,46,07,210 (consisting of 9,23,03,605 equity shares of face value of Rs 2 each). The Nomination and Remuneration Meeting commenced today at 09:00 a.m. and concluded at 09:30 am. Details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 are enclosed as Annexure A. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..